General Information of the Compound
Compound ID
CP0513853
Compound Name
3-[(2-chlorophenyl)methyl]-2-ethyl-7-piperazin-1-ylimidazo[4,5-b]pyridine
    Show/Hide
Structure
Formula
C19H22ClN5
Molecular Weight
355.873
Canonical SMILES
CCc1nc2c(ccnc2n1Cc1ccccc1Cl)N1CCNCC1
    Show/Hide
InChI
InChI=1S/C19H22ClN5/c1-2-17-23-18-16(24-11-9-21-10-12-24)7-8-22-19(18)25(17)13-14-5-3-4-6-15(14)20/h3-8,21H,2,9-13H2,1H3
    Show/Hide
InChIKey
CKMBZHIXVDVBQE-UHFFFAOYSA-N
Physicochemical Property
logP
3.105
Rotatable Bonds
4
Heavy Atom Count
25
Polar Areas
45.98
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 126720448
ChEMBL ID
CHEMBL4167974
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 177 nM
   TI
   LI
   LO
   TS